LIGAND PHARMACEUTICALS INCORPORATED Current Liabilities
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) had Current Liabilities of $46.74 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Liabilities, Current $46.74M.
- 2026-03-31: Liabilities, Current $40.67M.
- 2025-12-31: Liabilities, Current $37.45M.
- 2025-09-30: Liabilities, Current $30.54M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $46.74M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $40.67M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $37.45M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $30.54M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $64.73M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $58.68M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $37.11M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $24.77M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $18.57M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $17.82M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $16.78M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $15.73M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $29.39M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $98.93M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $98.81M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $135.24M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $167.85M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $42.58M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $41.66M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $36.30M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $52.50M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $95.81M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $100.11M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $42.30M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $29.26M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $20.44M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $17.00M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $35.70M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $108.98M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $186.78M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $82.25M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $793.34M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $632.85M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $246.98M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $238.87M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $231.68M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $225.84M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $227.00M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $227.13M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $226.13M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $220.35M 10-Q · filed 2016-11-14 | |
| 2016-03-31 | $12.24M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $222.82M 10-K · filed 2017-02-28 | $20.84M 10-K · filed 2016-02-26 |
| 2015-09-30 | $16.25M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $17.95M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $18.16M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $22.78M 10-K · filed 2016-11-14 | $28.94M 10-K · filed 2014-12-01 |
| 2014-09-30 | $18.43M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $18.62M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $21.00M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $28.94M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $32.46M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $32.57M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $33.02M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $35.44M 10-K/A · filed 2014-12-12 | |
| 2012-09-30 | $29.88M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $30.82M 10-Q/A · filed 2012-11-14 | $30.42M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $27.21M 10-Q/A · filed 2012-11-14 | |
| 2011-12-31 | $43.64M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $42.45M 10-Q/A · filed 2012-02-10 | |
| 2011-06-30 | $42.31M 10-Q/A · filed 2012-02-10 | |
| 2010-12-31 | $33.49M 10-K/A · filed 2012-11-14 |